Back to results
US 2022/0064123 A1Published application
(--)-Huperzine A Processes and Related Compositions and Methods of Treatment
AssigneeYale University
InventorsSeth Herzon, Maung Kyaw Moe Tun
Life of this patent
Estimating the term…
Abstract
The invention provides (1) processes for making substantially-pure (−) huperzine A and substantially-pure (−) huperzine A derivatives; (2) compositions useful in making substantially-pure (−) huperzine A and substantially-pure (−) huperzine A derivatives; and (3) methods of treating or preventing neurological disorders using substantially-pure (−) huperzine A and substantially-pure (−) huperzine A derivatives.
Claims4
1-12. (canceled)
A compound of the formula (I):
- wherein:
- R1 is selected from the group consisting of substituted or unsubstituted C1-C6 alkyl and substituted or unsubstituted ether;
- R2 and R5 are independently selected from the group consisting of H, substituted or unsubstituted C1-C6 alkyl, and CN, provided that when one of R2 or R5 is CN, the other must be H;
- X is halogen;
- R3 at each occurrence is independently selected from the group consisting of H, substituted or unsubstituted C1-C6 alkyl, ether, amino, and alkoxy;
- R4 is selected from the group consisting of Si(CH3)2Ph, substituted or unsubstituted C1-C6 alkyl, substituted or unsubstituted C1-C6 alkenyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl;
- A is C, N, or S;
- m is 0, 1, or 2;
- n is 0 or 1;
- or a pharmaceutically acceptable salt, enantiomer, diasteromer, solvate or polymorph thereof.
7 more elements
15-44. (canceled)
Dependencies are inferred from the claim text.